Dana-Farber | GenomeWeb


The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis. 

The large-scale study is designed to advance personalized medicine for pancreatic cancer to help meet the organization's goal of doubling patient survival rates by 2020.

Having sequenced close to 15,000 samples, the project is now taking steps toward integrating results fully into patient medical records.

Lasker Honorees

The Albert and Mary Lasker Foundation has announced this year's recipients of its prizes honoring basic and clinical research.

Though the results are preliminary, they suggest that a simpler method that doesn't require isolation of CTCs could potentially be as effective as current CTC-based approaches for AR-V7 testing.

Single-cell RNA sequencing on thousands of tumor and surrounding cells from 19 melanoma samples revealed subsets of cells with apparent resistance potential.

Exome sequences and copy number patterns suggest lung adenocarcinoma and squamous cell carcinoma are each marked by specific somatic mutations and driver genes.

Dana-Farber and the Broad are using social media to identify extraordinary responders and other outlier patients to study what makes them genetically unique.

By predicting neoantigens from mutation data, researchers found that colorectal tumors with high loads are infiltrated by a large number of lymphocytes.

A prospective study used droplet digital PCR to search for treatment-informative EGFR and KRAS mutations in cell-free DNA from non-small cell lung cancer patients. 


National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.